Industrial Pollution Not Just Dirty
Benzene is a chemical that’s used in the making of all sorts of products, ranging from plastics to detergents. It’s also a chemical that’s been linked to blood cancers.
These Cells Can Stem Blood Cancer
Being diagnosed with leukemia or lymphoma can be a major life change for patients. With new advances in medicine, they may have some respite.
Non-Hodgkin Rx Trial Halted
A new medication that was thought to hold promise for non-Hodgkin lymphoma has been stopped. Pfizer announced it has halted its trial of the investigational compound inotuzumab ozogamicin.
Back to Hospital after Stem Cell Transplant
Stem cell transplants can – and do – save the lives of very sick kids. New research has discovered that the transplant is often just the start of hospital stays for these young patients.
No Need to Fear Lupus Medications
Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?
Battling Fatigue Decades Later
Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.
Cancer Rx Granted Accelerated FDA Approval Path
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.
New Vaccine Recommendation for Adults
Adults with certain immune system conditions often require different recommendations for the vaccines they can and should receive. A new vaccine has been added to these recommendations.
One Rx Better Than Another For Melanoma?
Two medications are approved in the US to treat advanced melanoma. Zelboraf ( vemurafenib ) was approved in September, 2012. DTIC-Dome ( dacarbazine ) is used to treat Hodgkin's lymphoma as well as melanoma. Which is the better medication?
The Wild Card in Lymphoma
Cancer in one person can behave very differently than it might in another person. That’s because each person’s genes are unique. So some new cancer treatments can target the individual’s unique genetic fingerprint. Scientists are exploring possible new targets in lymphoma.